The U.S. pharmaceutical market dipped 4.1% year-over-year in the most recent quarter-to-date figures, according to recent IQVIA research. New prescription sales fell 4.4%. Brand-name drug sales, however, saw a modest growth rate of 1.8% while generic drug sales, which made up 80% of all sales, fell 4.5% in the quarter. One bright spot in the…